Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer
A Phase 0 Study Evaluating the Systemic Bioavailability and Pharmacodynamic Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer
Sponsor: National Cancer Institute (NCI)
A NA clinical study on Carcinoma in Situ and Dysplasia, this trial is completed. The trial is conducted by National Cancer Institute (NCI) and has accumulated 9 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2023 — Jul 2024 [monthly]
Completed NA
-
May 2021 — May 2023 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
May 2020 — Jan 2021 [monthly]
Recruiting NA
-
May 2019 — May 2020 [monthly]
Recruiting NA
-
Jun 2018 — May 2019 [monthly]
Recruiting NA
-
Sep 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- University of Arizona
- University of Pittsburgh
For direct contact, visit the study record on ClinicalTrials.gov .